In Vivo Gene Transfer into Adult Stem Cells in Unconditioned Mice by in Situ Delivery of a Lentiviral Vector

Molecular Therapy

Volumn 14, Issue 4, 2006, Pages 514-524

  Worsham, D Nicole ^a   Schuesler, Todd ^a   von Kalle, Christof ^a,b   Pan, Dao ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

bone marrow transplantation; hematopoiesis; hematopoietic stem cells; in vivo gene transfer; intrafemoral injection; lentiviral vectors; mesenchymal stem progenitor cells

Indexed keywords

ATAXIN 1; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PROTEIN KINASE LYN; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL SUBPOPULATION; COLONY FORMING UNIT; CONTROLLED STUDY; FIBROBLAST; GENE TRANSFER; GENETIC TRANSDUCTION; GRAFT REJECTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VIVO STUDY; LYMPHOID CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RECIPIENT; TIME;

AGING; ANIMALS; BIOLOGICAL MARKERS; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL LINE; CELL LINEAGE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INJECTIONS, INTRALESIONAL; LENTIVIRUS; LYMPHOCYTES; MICE; MYELOID CELLS; RNA, MESSENGER; TRANSPLANTATION CONDITIONING;

ANIMALIA; LENTIVIRUS;

EID: 33748069163     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2006.05.014     Document Type: Article

References (49)

1. Kay M.A., Glorioso J.C., and Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7 (2001) 33-40
2. Blomer U., Naldini L., Kafri T., Trono D., Verma I.M., and Gage F.H. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71 (1997) 6641-6649
3. Miyoshi H., Takahashi M., Gage F.H., and Verma I.M. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA 94 (1997) 10319-10323
4. Kafri T., Blomer U., Peterson D.A., Gage F.H., and Verma I.M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17 (1997) 314-317
5. Johnson L.G., Olsen J.C., Naldini L., and Boucher R.C. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Ther. 7 (2000) 568-574
6. Gusella G.L., Fedorova E., Hanss B., Marras D., Klotman M.E., and Klotman P.E. Lentiviral gene transduction of kidney. Hum. Gene Ther. 13 (2002) 407-414
7. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283 (1999) 682-686
8. Case S.S., et al. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl. Acad. Sci. USA 96 (1999) 2988-2993
9. Pan D., et al. Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. Mol. Ther. 6 (2002) 19-29
10. Follenzi A., Sabatino G., Lombardo A., Boccaccio C., and Naldini L. Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum. Gene Ther. 13 (2002) 243-260
11. Pan D., et al. Metabolic and neuropathologic correction of Hurler syndrome by a single intravenous injection of lentiviral vector to newborn mice. Mol. Ther. 7 (2003) s76
12. Hacein-Bey-Abina S., et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346 (2002) 1185-1193
13. Aiuti A., et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296 (2002) 2410-2413
14. Barese C.N., Goebel W.S., and Dinauer M.C. Gene therapy for chronic granulomatous disease. Expert Opin. Biol. Ther. 4 (2004) 1423-1434
15. Baum C., et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101 (2003) 2099-2114
16. Jiang Y., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
17. Herzog E.L., Chai L., and Krause D.S. Plasticity of marrow derived stem cells. Blood 102 (2003) 3483-3493
18. McCauslin C.S., et al. In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animals. Blood 102 (2003) 843-848
19. Sastry L., et al. Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses. Mol. Ther. 8 (2003) 830-839
20. Becker K., Pan D., and Whitley C.B. Real-time quantitative polymerase chain reaction to assess gene transfer. Hum. Gene Ther. 10 (1999) 2559-2566
21. + Flt3-L-mobilized cells in nonhuman primates. Blood 101 (2003) 2199-2205
22. + cells in synergy with other cytokines, enhances their ex vivo expansion and engraftment into NOD/SCID mice. Stem Cells 24 (2006) 55-64
23. Bunnell B.A., Muul L.M., Donahue R.E., Blaese R.M., and Morgan R.A. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 92 (1995) 7739-7743
24. Pan D., Stroncek D.F., and Whitley C.B. Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysaccharidosis type I using a bioreactor. J. Gene Med. 6 (2004) 1293-1303
25. Hanenberg H., Xiao X.L., Dilloo D., Hashino K., Kato I., and Williams D.A. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat. Med. 2 (1996) 876-882
26. Newbound G.C., Cooper J.R., O'Rourke J.P., Baskin C.R., and Bunnell B.A. Analysis of gene transfer efficiency of retrovirus producer cell transplantation for in situ gene transfer to hematopoietic cells. Exp. Hematol. 29 (2001) 163-173
27. Nelson D.M., Metzger M.E., Donahue R.E., and Morgan R.A. In vivo retrovirus-mediated gene transfer into multiple hematopoietic lineages in rabbits without preconditioning. Hum. Gene Ther. 8 (1997) 747-754
28. Cherry S.R., Biniszkiewicz D., van Parijs L., Baltimore D., and Jaenisch R. Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol. Cell. Biol. 20 (2000) 7419-7426
29. Pfeifer A., Ikawa M., Dayn Y., and Verma I.M. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc. Natl. Acad. Sci. USA 99 (2002) 2140-2145
30. Lois C., Hong E.J., Pease S., Brown E.J., and Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295 (2002) 868-872
31. Schroder A.R., Shinn P., Chen H., Berry C., Ecker J.R., and Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110 (2002) 521-529
32. Wu X., Li Y., Crise B., and Burgess S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science 300 (2003) 1749-1751
33. Hammond S.M., Crable S.C., and Anderson K.P. Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. Leuk. Res. 29 (2005) 89-97
34. Baksh D., Song L., and Tuan R.S. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J. Cell. Mol. Med. 8 (2004) 301-316
35. Crevensten G., et al. Intervertebral disc cell therapy for regeneration: mesenchymal stem cell implantation in rat intervertebral discs. Ann. Biomed. Eng. 32 (2004) 430-434
36. Chamberlain J.R., et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303 (2004) 1198-1201
37. Mangi A.A., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9 (2003) 1195-1201
38. Jin H.K., Carter J.E., Huntley G.W., and Schuchman E.H. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. J. Clin. Invest. 109 (2002) 1183-1191
39. Ortiz L.A., et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. USA 100 (2003) 8407-8411
40. Glennie S., Soeiro I., Dyson P.J., Lam E.W., and Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105 (2005) 2821-2827
41. Horwitz E.M., et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA 99 (2002) 8932-8937
42. Petite H., et al. Tissue-engineered bone regeneration. Nat. Biotechnol. 18 (2000) 959-963
43. Koc O.N., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 18 (2000) 307-316
44. VandenDriessche T., et al. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100 (2002) 813-822
45. High K.A. The risks of germline gene transfer. Hastings Cent. Rep. 33 (2003) 3
46. Mazurier F., Doedens M., Gan O.I., and Dick J.E. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat. Med. 9 (2003) 959-963
47. Sun S., et al. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cells 21 (2003) 527-535
48. Zuk P.A., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7 (2001) 211-228
49. + cells from the cord blood of ADA-deficient SCID neonates. Nat. Med. 9 (2003) 463-468